DJ Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 2.27% to $120.37 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.10% to 5,892.58 and the Dow Jones Industrial Average falling 0.21% to 42,051.06.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 49.42% below its 52-week high of $238.00, which the company achieved on July 12th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.40% to $146.36, Pfizer Inc. $(PFE)$ fell 3.72% to $22.02, and AbbVie Inc. $(ABBV)$ fell 5.62% to $177.44.
Trading volume (1.5 M) remained 284,450 below its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 14, 2025 17:09 ET (21:09 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。